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Malaria remains an important 
public health problem worldwide 
especially in the tropics and it is an 
important cause of morbidity in 
pregnancy. In Nigeria, it is a leading 
cause of outpatient clinic consultation 
and is among the three common 
causes of death in Nigeria.1 Malaria in 
pregnancy can be associated with 
serious complications for the mother or 
the developing foetus. The maternal 
complications include haemolytic 
anaemia, acute febrile attacks, 
cerebral malaria, renal failure and 
maternal mortality.2 It can also lead to 
early pregnancy losses, preterm 
delivery, low birth weight and 
intrauterine foetal death.3,4  
The “Roll Back Malaria” initiative 
was launched as a major initiative in 
the management of malaria at all 
health care levels worldwide including 
Nigeria using evidence based 
strategies. It recommends 
environmental vector control (using 
insecticide treated/ impregnated 
mosquito nets), prompt and effective 
case management of malaria using 
Artemisinin based combination therapy 
(ACT) and effective malaria 
chemoprophylaxis in pregnancy using 
intermittent preventative treatment 
(IPT).5 The use of IPT has been shown 
to reduce the incidence of anaemia in 
pregnancy, increase the birth weight of 
the baby, and reduce the burden of 
placental malaria, thus leading to 
better materno-foetal outcomes.4 
Evidence based recommendations 
especially when they result in a 
significant change in practice may not 
be promptly adopted by care providers 
or patients.6,7 The use IPT for malaria 
chemoprophylaxis has not been well 
documented in our environment. The 
authors of this work expect that the 
data from this work assist in evaluating 
compliance with the use of IPT for 
malaria chemoprophylaxis in 
pregnancy and the subsequent 
pregnancy outcome and also assist 
policy makers/care providers design 
appropriate strategies to reduce 
morbidity and mortality associated with 
malaria in pregnancy. 
METHODS 
The study design used was a 
retrospective study using a cohort of 
pregnant who received antenatal care 
at the University of Benin Teaching 
Hospital, Nigeria. The hospital is 
referral center serving a population of 
about 3 million people in the Niger-
Delta region of Nigeria. All booked 
women who had antenatal care at 
UBTH, delivered at UBTH and 
attended the 6th week post-natal clinic 
appointment in the Hospital from the 
23rd November to the 11th December 
2009 were recruited for this study. 
Vol. 12 No. 1 December, 2010  Malaria in pregnancy: experience with intermittent preventive treatment... 
 15  
 
The information of interest 
collected from case notes included 
their ante-natal history including the 
use of malarial chemoprophylaxis and 
treatment for malaria during 
pregnancy. In addition, the outcome of 
labour and materno-foetal outcome 
were also evaluated. Data collected 
was entered into a data extraction form 
designed for the study from the case 
notes of patients after they had 
presented at their sixth week 
appointment for the post natal clinic. 
A database was generated and 
analysed using SPSS version 16 
(SPSS, Chicago, IL, USA) for 
Windows. Data was expressed as 
percentages, means, and standard 
deviations for categorical and 
continuous variables respectively. The 
differences in proportion were 
evaluated using Chi-square test for 
categorical variables and the t test for 
continuous variables. Statistical 
significance was set at p value <0.05. 
RESULT 
Data used in this study was 
collected from one hundred and five 
(105) women from the University of 
Benin Teaching Hospital, Benin City, 
Nigeria. The demographics and clinical 
characteristics of the study population 
are shown in Table I. 
The mean age of the women in this 
study was (Mean±SD) 30.8±4.5 years. 
Of the one hundred and five women, 
47 women (44.8%) were primiparous, 
53 (50.5%) were multiparous and 5 
(4.8%) were grandmultiparous. Most 
(66.6%) of the women in the study 
were of a post-secondary level of 
education, which included 
qualifications such as HND, BSc, MSc 
and MBBS. Five patients (4.8%) had a 
primary level of education, and 30 
(28.6%) patients had only reached a 
secondary level of education, 
specifically a senior secondary school 
examination (SSCE). 
The retroviral disease status of 
each patient enrolled in the study was 
collected, and it was found that 93 
(88.6%) of the patients were confirmed 
negative for the disease, while 7 
(6.6%) patients had a positive 
diagnosis of HIV and 5 (4.8%) patients 
did not have their HIV status indicated 
in the case notes. 
In the majority of the patients 
(61.9%) who had their packed cell 
volume (PCV) determined at booking, 
results revealed that they were not 
anaemic, and no patient presented 
with a PCV of ≤24%. The most 
common presenting gestational age of 
women at booking was at 11-20 weeks 
(46.7%) and 21-30 weeks (30.5%). 
 
Table I: Clinical characteristics of study 
population 
Variables Number (%) 
Mean Age (Mean ± SD) years 
No. of women  <20 years 
No. of women   20-35 years 
No. of women  >35 years 


































Gestational age at Booking 
Not Recorded 
≤10 weeks 
11- 20 weeks 
21- 30 weeks 
















*PCV= packed cell volume 
In Table II, the outcome of 
pregnancy among the study population 
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is shown. The mean number of doses 
of chemoprophylaxis given as 
intermittent malarial treatment (IPT) 
was 1.4±0.6 (Mean±SD) while 20 
patients (19.1%) were not given 
chemoprophylaxis with IPT. 
The prevalence of women amongst 
the study group with anaemia in 
pregnancy was very low (1.9%), as 
only 2 patients were clinically 
diagnosed with it, whilst there was a 
high prevalence (41%) of women in 
this study with malaria parasitaemia in 
pregnancy.  
The most frequent (53.4%) period 
of malarial parasitaemia amongst the 
study group was in the late the third 
trimester, from thirty one weeks. 
 
Table II: Outcome of pregnancy in study population 
Variables Results 











Prevalence of women with Anaemia in Pregnancy 2/105 (1.9%) 
  




Mean Gestational Age in weeks of Malarial Parasitaemia 
in Pregnancy  (Mean ± SD) 
≤10 weeks 
11 – 20 weeks 
21 - 30 weeks   
≥31 weeks 
 






Number of Patients Admitted for Malaria  in Pregnancy 2/43 (4.7%) 
 
Gestational Age at Delivery 
24 – 32 weeks 
33 – 40 weeks 
≥ 41 weeks 
 
1 (1%) 
86 (81.9%)  
18 (17.1%) 
 






The most frequent (53.4%) period of 
malarial parasitaemia amongst the 
study group was in the late the third 
trimester, from thirty one weeks (figure 
1). 
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Figure 1: Relationship between malaria parasitaemia at different gestational age 
and parity group 
The mean birth weight (Mean±SD) 
was 3.2±0.5 kilograms with most 
(87.7%) of the babies born with a 
normal birth weight within the range of 
2.5-3.9kg, whilst 6.6% of the babies 
born had low birth weights of less than 
2.5kg. There were a total number of 
106 babies born to 105 women (one 
mother had a twin pregnancy). 
Table III: Foetal Outcome among 
the study population 
Variables Results 
Mean Birth Weight  

















1st Minute APGAR score 
(Mean) 








In this study, about half of the study 
population were primiparous women 
(never delivered before) who are more 
vulnerable to malaria in pregnancy 
compared to multiparous women (one 
or more previous deliveries).8 In 
addition, about 60% of the study 
population registered for antenatal 
care before 20 weeks gestational age. 
This is important because it re-
enforces the need for optimum 
chemoprophylaxis against malaria in 
pregnancy as a substantial amount of 
pregnant women who are vulnerable to 
malaria present for antenatal care at a 
relatively early gestational age in 
pregnancy (after quickening, usually 
between 16-20 weeks) when IPT can 
be administered with good effect. 
Although more than 80% of the 
women received IPT with about half 
getting two or three doses during 
pregnancy, about one-fifth of the study 
population were not documented to 
have received IPT. This could have 
adverse implications from a public 
health perspective with respect to 
curtailing the impact of malaria in 
pregnancy. However, since this was a 
retrospective study using hospital 
records, it is possible this could be due 
to improper documentation and record 
keeping and some patients who are 
allergic to sulphonamides (present in the 
Sulphadoxine-pyrimethamine antimalarial 
drug combination used for IPT) may 
have used alternative drugs for 
chemoprophylaxis. The widespread 
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administration of IPT among a majority 
of the study population may partly 
account for the low prevalence of 
anaemia and hospitalisation for clinical 
malaria during pregnancy. 
Out of the 57 women who had 
malaria parasitaemia during pregnancy, 
about more than half occurred after 30 
weeks gestation. In addition, more 
than four-fifth of malaria parasitaemia 
occurred after 20 weeks of pregnancy 
compared with less than 15% before 
twenty weeks gestation. This highlights 
the increasing vulnerability of pregnant 
women to malaria as pregnancy 
advances and the value of having the 
first contact with between pregnant 
women and health care facilities early in 
pregnancy. Furthermore, the initiation 
of chemoprophylaxis from early 
pregnancy becomes even more 
relevant to reduce the complications 
that may be associated with malaria in 
pregnancy.1,2  
The overall satisfactory maternal, 
foetal and perinatal outcome can be 
considered a reflection of the quality of 
care available in the facility. However, 
the findings from the study need to be 
interpreted with caution. It was a 
retrospective study in design which 
makes it prone to problems peculiar 
with such a study design including 
suboptimal data entry. In addition, the 
relatively small sample population and 
the use of only patients attending a 
University Teaching Hospital in a 
country without universal access to 
antenatal care, home delivery and 
ignorance is widespread9 limits the 
extrapolation of the results to the 
general population. However, the 
study is still very relevant as it provides 
local data on the use and benefits of 
IPT, an important strategy for reducing 
malaria in pregnancy which is a 
component of the millennium 
development goal 6. 
In conclusion, the findings from the 
study reveal that it is feasible to use 
Sulphadoxine-pyrimethamine as IPT 
for malaria chemoprophylaxis among 
pregnant women receiving antenatal 
care at UBTH. Pregnant women 
should have first contact in pregnancy 
with health care facilities at an early 
gestational age when IPT can be 
administered effectively to reduce the 
impact of malaria in pregnancy. This 
information is important for health 
workers providing care to pregnant 
women in malaria endemic regions 
and to reduce the adverse impact of 
malaria on foetal outcome. 
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